TG Therapeutics | TGTX - L'Utile Ante Imposte





L'Utile Ante Imposte Cambiamento Data
AbbVie USD 5.57B 2.9B 2026-03
Alaunos Therapeutics USD -7.84M 633K 2023-12
Amgen USD 1.51B 2.41B 2025-12
Ardelyx USD -400K 467K 2025-12
Arrowhead Research USD 28.27M 7.85M 2025-12
Bayer EUR -1.16B 735M 2025-09
Biogen USD 377.7M 433.7M 2026-03
Corcept Therapeutics USD 9.91M 5.33M 2025-12
Curis USD 19.36M 33.34M 2025-12
Gilead Sciences USD 2.08B 1.56B 2025-12
Infinity Pharmaceuticals USD -9.96M 1.09M 2023-06
J&J USD 7.82B 2.86B 2026-03
Karyopharm Therapeutics USD -39.9M 9.01M 2025-12
Novartis USD 4.64B 445M 2025-12
Novavax USD 17.9M 220.94M 2025-12
PTC Therapeutics USD -139.08M 116.01M 2025-12
Puma Biotechnology USD 20.61M 24.76M 2024-09
Regeneron Pharmaceuticals USD 1.04B 719.6M 2025-12
Roche Holding CHF 4.79B 3.01B 2025-06
TG Therapeutics USD 45.09M 19.18M 2025-12
Verastem USD -32.92M 944K 2025-12
Vertex Pharmaceuticals USD 1.3B 15.8M 2025-09